Kristen Fortney is the co-founder and CEO of BioAge Labs, a clinical-stage biotechnology company developing a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging. In this conversation with Stanford adjunct lecturer Toby Corey, Fortney discusses strategies for reducing risk along the path to developing world-changing therapies.

Video clips from: Derisking Biotech [Entire Talk]

2 minutes

Opportunities in Aging and Biotech

Watch now

3 minutes

Derisking Milestones in Biotech

Watch now

2 minutes

Bringing New Biotech Treatments to Market

Watch now

Share Post